TABLE 1.
Demographics and clinical measures of the Parkinson’s disease (PD) and healthy controls (HC) group.
| Characteristics | HC (n = 52) Mean ± SD | PD (n = 47) Mean ± SD | p |
| M/F (n) | 28/24 | 32/15 | 0.083 |
| Age (years) | 70.39 ± 6.88 | 68.36 ± 8.98 | 0.216 |
| Height (m) | 1.69 ± 0.08 | 1.70 ± 0.08 | 0.542 |
| Mass (kg) | 81.13 ± 15.15 | 80.27 ± 15.67 | 0.786 |
| BMI (kg/m2) | 28.29 ± 4.23 | 27.62 ± 4.62 | 0.455 |
| MoCA | 27.61 ± 2.39 | 26.28 ± 3.60 | 0.037 |
| ABCs (0–100%) | 91.02 ± 11.65 | 80.88 ± 16.18 | 0.003 |
| Medication (LEDD, mg/day) | 415.08 ± 212.61 | ||
| Time from Clinical Diagnosis (months) | 26.42 ± 5.48 | ||
| Hoehn and Yahr (n) | HY I–7 (15%) | ||
| HY II–38 (81%) | |||
| HY III–2 (4%) | |||
| MDS-UPDRS III | 31.53 ± 9.79 | ||
| (HY I–16.6 ± 4.73) | |||
| (HY II–33.28 ± 8.81) | |||
| (HY III–35.5 ± 0.71) |
M, Males; F, Females; BMI, Body Mass Index; MoCA, Montreal Cognitive Assessment; ABCs, Activities Specific Balance Confidence scale; LEDD, Levodopa Equivalent Daily Dose; MDS-UPDRS, Movement Disorder Society Unified Parkinson’s Disease Rating Scale. Bold values mean a significant difference between PD and HC.